Search for: "United States v. Mayne"
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
13 Dec 2011, 5:39 am
United States, 930 F.2d 867, 869 (Fed. [read post]
25 Nov 2012, 5:42 pm
” Instead, the district court, citing United States v. [read post]
8 Jul 2014, 11:00 am
Board Decision and Girl Scouts of the United States” Commentator: Martha Jones Closing Comments: Sarah Barringer Gordon [read post]
30 Jan 2009, 1:05 am
United States [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
17 Jan 2008, 10:00 pm
, (Chicago IP Litigation Blog), (more from Chicago IP Litigation Blog), (Washington State Patent Law Blog), (Harold Wegner), Global101 reasons for not selling your unused trade marks: (IPKat),ICANN to battle domain name tasting: (Trademark Blog), (related coverage from Trademark Blog),Is a patent a monopoly? [read post]
2 Jul 2012, 1:38 pm
In re Mayne, 104 F.3d 1339, 1341 (Fed. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
7 May 2012, 12:06 pm
Mayne v. [read post]
26 Feb 2011, 3:47 pm
Mayne Pharma (USA) Inc., 467 F.3d 1370, 1379 (Fed. [read post]
28 Apr 2022, 4:17 pm
We need to know exactly who in the company was aware of this failure and the alleged attempts to hide this information from the FDA,” DeLauro said during a meeting on the Fiscal Year 2023 Budget Request for the United States Department of Agriculture. [read post]
